Literature DB >> 17555445

A practical strategy for the routine use of BIOMED-2 PCR assays for detection of B- and T-cell clonality in diagnostic haematopathology.

Hongxiang Liu1, Anthony J Bench, Chris M Bacon, Karen Payne, Yuanxue Huang, Mike A Scott, Wendy N Erber, John W Grant, Ming-Qing Du.   

Abstract

BIOMED-2 polymerase chain reaction (PCR) assays for clonality analysis of immunoglobulin (IG) and T-cell receptor (TCR) gene rearrangements were evaluated in routine haematopathological practice where paraffin-embedded tissues constitute the majority of specimens. One hundred and twenty-five fresh/frozen and 316 paraffin specimens were analysed for DNA quality and clonality. Seventy-nine per cent of paraffin specimens yielded PCR products of over 300 bp. These specimens and all fresh/frozen specimens were analysed with the complete set of BIOMED-2 reactions for IG (8 reactions) and/or TCR (6 reactions) gene rearrangements. The rate of detection of clonality was 96% in mature B-cell neoplasms and 98% in mature T-cell neoplasms and there were no significant differences in these rates between paraffin and fresh/frozen specimens. As the value of sole use of any individual BIOMED-2 reaction in clonality detection was limited, we assessed combinations of reactions that gave the greatest sensitivity with fewest reactions and were applicable for both fresh/frozen and paraffin specimens. For IG gene rearrangements, three reactions combining one targeting the IG heavy chain framework-2 region and two targeting the IG kappa locus achieved a 91% detection rate. For TCR gene rearrangements, the two TCR gamma reactions gave a 94% detection rate. We therefore recommend this strategy as the first-line assays for routine B- and T-cell clonality analysis in diagnostic haematopathology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17555445     DOI: 10.1111/j.1365-2141.2007.06618.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  26 in total

Review 1.  The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies.

Authors:  Anna Gazzola; Claudia Mannu; Maura Rossi; Maria Antonella Laginestra; Maria Rosaria Sapienza; Fabio Fuligni; Maryam Etebari; Federica Melle; Elena Sabattini; Claudio Agostinelli; Francesco Bacci; Carlo Alberto Sagramoso Sacchetti; Stefano Aldo Pileri; Pier Paolo Piccaluga
Journal:  Ther Adv Hematol       Date:  2014-04

Review 2.  Malleable immunoglobulin genes and hematopathology - the good, the bad, and the ugly: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.

Authors:  Adam Bagg
Journal:  J Mol Diagn       Date:  2008-08-07       Impact factor: 5.568

3.  Fixed nuclei as alternative template of BIOMED-2 multiplex polymerase chain reaction for immunoglobulin gene clonality testing in B-cell malignancies.

Authors:  Yuan Tang; Jie Chen; Jianchao Wang; Ke Zheng; Dianying Liao; Xiaomei Liao; Weiping Liu; Lin Wang
Journal:  Am J Blood Res       Date:  2015-12-25

4.  Nasal-type NK/T-cell lymphomas are more frequently T rather than NK lineage based on T-cell receptor gene, RNA, and protein studies: lineage does not predict clinical behavior.

Authors:  Mineui Hong; Taehee Lee; So Young Kang; Suk-Jin Kim; Wonseog Kim; Young-Hyeh Ko
Journal:  Mod Pathol       Date:  2016-03-25       Impact factor: 7.842

Review 5.  Intraocular collision tumour: case report and literature review.

Authors:  Sarah E Coupland; Andrew Dodson; Hongxiang Liu; Ming-Qing Du; Martina Angi; Bertil E Damato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-12       Impact factor: 3.117

6.  KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.

Authors:  A Clipson; M Wang; L de Leval; M Ashton-Key; A Wotherspoon; G Vassiliou; N Bolli; C Grove; S Moody; L Escudero-Ibarz; G Gundem; K Brugger; X Xue; E Mi; A Bench; M Scott; H Liu; G Follows; E F Robles; J A Martinez-Climent; D Oscier; A J Watkins; M-Q Du
Journal:  Leukemia       Date:  2014-11-27       Impact factor: 11.528

7.  Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing.

Authors:  Ming Wang; Leire Escudero-Ibarz; Sarah Moody; Naiyan Zeng; Alexandra Clipson; Yuanxue Huang; Xuemin Xue; Nicholas F Grigoropoulos; Sharon Barrans; Lisa Worrillow; Tim Forshew; Jing Su; Andrew Firth; Howard Martin; Andrew Jack; Kim Brugger; Ming-Qing Du
Journal:  J Mol Diagn       Date:  2015-07-09       Impact factor: 5.568

8.  Detection of monoclonal IGH rearrangements in circulating cells from healthy first-degree relatives of patients with multiple myeloma.

Authors:  Herbert García-Castillo; Evelia Leal-Ugarte; Pablo César Ortiz Lazareno; Esperanza Barrera-Chairez; Víctor Hugo Rosales-García; Patricio Barros-Núñez
Journal:  Med Oncol       Date:  2014-03-01       Impact factor: 3.064

9.  The frequency of immunoglobulin heavy chain gene and T-cell receptor gamma-chain gene rearrangements and Epstein-Barr virus in ALK+ and ALK- anaplastic large cell lymphoma and other peripheral T-cell lymphomas.

Authors:  Brent T Tan; Katie Seo; Roger A Warnke; Daniel A Arber
Journal:  J Mol Diagn       Date:  2008-10-02       Impact factor: 5.568

10.  Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI).

Authors:  Dipti Talaulikar; Bruce Shadbolt; Jane E Dahlstrom; Anne McDonald
Journal:  J Hematol Oncol       Date:  2009-11-22       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.